Vaxzevria (previously COVID-19 Vaccine AstraZeneca) - direct healthcare professional communication (DHPC)
Chimpanzee Adenovirus encoding the SARS CoV 2 Spike glycoprotein (ChAdOx1-S)
DHPCHuman
About
This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.
Documents
Direct healthcare professional communication (DHPC): Vaxzevria (previously COVID-19 Vaccine AstraZeneca): Risk of thrombocytopenia and coagulation disorders
English (EN)
(166.6 KB - PDF)View
Key facts
- Medicine name
- Vaxzevria (previously COVID-19 Vaccine AstraZeneca)
- Active substance
- Chimpanzee Adenovirus encoding the SARS CoV 2 Spike glycoprotein (ChAdOx1-S)
- Therapeutic area (MeSH)
- COVID-19 virus infection
- Regulatory outcome
- Variation
- DHPC type
- Safety signal
- Human ATC codes
- J07BX03
- Dissemination date
- 24/03/2021